Status:

UNKNOWN

Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation

Lead Sponsor:

Linkoeping University

Conditions:

Covid19

Cardiopulmonary Disease

Eligibility:

All Genders

18+ years

Brief Summary

The physiological derangements in subjects suffering from long-term symptoms following a Covid-19 infection (Post-COVID-19 Syndrome) are poorly understood and evaluated. This study will recruit subjec...

Detailed Description

The physiological derangements in subjects suffering from long-term symptoms following a Covid-19 infection (Post-COVID-19 Syndrome) are poorly understood and evaluated. For example, the extent to whi...

Eligibility Criteria

Inclusion

  • Confirmed or clinically highly suspected Covid19-infection
  • Symptom duration at least 12 weeks following first occurence of symptoms
  • No other disease that better could explain the symptoms than Covid19

Exclusion

  • Age \<18 years
  • Unability to perform a maximal exercise test
  • Unability to understand written or spoken Swedish

Key Trial Info

Start Date :

April 20 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2022

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04859894

Start Date

April 20 2021

End Date

June 1 2022

Last Update

October 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept Health, Medicine and Caring Sciences

Linköping, Östergötland County, Sweden, 58737